Pan Boyu, Zhu Han, Yang Jiaqi, Wang Liangjiao, Chen Zizhen, Ma Jian, Zhang Bo, Pan Zhanyu, Ying Guoguang, Li Shao, Liu Liren
Department of Molecular Pharmacology, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China.
National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
Cancer Biol Med. 2024 Oct 28;21(11):1067-77. doi: 10.20892/j.issn.2095-3941.2023.0442.
The presence of complex components in Chinese herbal medicine (CHM) hinders identification of the primary active substances and understanding of pharmacological principles. This study was aimed at developing a big-data-based, knowledge-driven algorithm for predicting central components in complex CHM formulas.
Network pharmacology (TCMSP) and clinical (GEO) databases were searched to retrieve gene targets corresponding to the formula ingredients, herbal components, and specific disease being treated. Intersections were determined to obtain disease-specific core targets, which underwent further GO and KEGG enrichment analyses to generate non-redundant biological processes and molecular targets for the formula and each component. The ratios of the numbers of biological and molecular events associated with a component were calculated with a formula, and entropy weighting was performed to obtain a fitting score to facilitate ranking and improve identification of the key components. The established method was tested on the traditional CHM formula Danggui Sini Decoction (DSD) for gastric cancer. Finally, the effects of the predicted critical component were experimentally validated in gastric cancer cells.
An algorithm called Chinese Herb Medicine-Formula . Ingredients Efficacy Fitting & Prediction (CHM-FIEFP) was developed. Ferulic acid was identified as having the highest fitting score among all tested DSD components. The pharmacological effects of ferulic acid alone were similar to those of DSD.
CHM-FIEFP is a promising method for identifying pharmacological components of CHM formulas with activity against specific diseases. This approach may also be practical for solving other similarly complex problems. The algorithm is available at http://chm-fiefp.net/.
中药中复杂成分的存在阻碍了主要活性物质的鉴定和药理原理的理解。本研究旨在开发一种基于大数据、知识驱动的算法,用于预测复杂中药方剂中的核心成分。
检索网络药理学(TCMSP)和临床(GEO)数据库,以获取与方剂成分、草药成分及所治疗的特定疾病相对应的基因靶点。确定交集以获得疾病特异性核心靶点,对其进行进一步的基因本体(GO)和京都基因与基因组百科全书(KEGG)富集分析,以生成方剂及其各成分的非冗余生物过程和分子靶点。用公式计算与某一成分相关的生物和分子事件数量的比值,并进行熵权处理以获得拟合分数,便于排名并提高关键成分的识别。将所建立的方法应用于治疗胃癌的传统中药方剂当归四逆汤(DSD)进行测试。最后,在胃癌细胞中通过实验验证预测关键成分的作用。
开发了一种名为“中药方剂成分功效拟合与预测”(CHM-FIEFP)的算法。在所有测试的DSD成分中,阿魏酸被确定具有最高的拟合分数。单独阿魏酸的药理作用与DSD相似。
CHM-FIEFP是一种有前景的方法,可用于鉴定对特定疾病具有活性的中药方剂的药理成分。该方法对于解决其他类似的复杂问题可能也具有实用性。该算法可在http://chm-fiefp.net/获取。